1/12
01:41 am
ocs
Oculis Holding (NasdaqGM:OCS) Valuation Check As Privosegtor Wins FDA Breakthrough Therapy Status [Yahoo! Finance]
Low
Report
Oculis Holding (NasdaqGM:OCS) Valuation Check As Privosegtor Wins FDA Breakthrough Therapy Status [Yahoo! Finance]
1/11
06:40 am
ocs
Why Oculis Holding (OCS) Is Up 15.3% After FDA Breakthrough Status For Privosegtor In Optic Neuritis [Yahoo! Finance]
Low
Report
Why Oculis Holding (OCS) Is Up 15.3% After FDA Breakthrough Status For Privosegtor In Optic Neuritis [Yahoo! Finance]
1/8
04:00 am
ocs
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
Medium
Report
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
1/6
04:23 am
ocs
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis [Yahoo! Finance]
Medium
Report
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis [Yahoo! Finance]
1/6
04:00 am
ocs
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
Medium
Report
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
12/19
10:09 am
ocs
Oculis (NASDAQ:OCS) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Oculis (NASDAQ:OCS) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.
12/19
08:04 am
ocs
Oculis (NASDAQ:OCS) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock.
Low
Report
Oculis (NASDAQ:OCS) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock.
12/3
09:05 am
ocs
Oculis (NASDAQ:OCS) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $55.00 price target on the stock.
Low
Report
Oculis (NASDAQ:OCS) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $55.00 price target on the stock.
11/16
09:36 pm
ocs
Is Oculis Holding (NasdaqGM:OCS) Fairly Valued? A Closer Look After Recent Share Movement [Yahoo! Finance]
Low
Report
Is Oculis Holding (NasdaqGM:OCS) Fairly Valued? A Closer Look After Recent Share Movement [Yahoo! Finance]
11/15
01:42 am
ocs
Low
Report
11/13
12:56 pm
ocs
Oculis (NASDAQ:OCS) had its price target lowered by analysts at Bank of America Corporation from $30.00 to $29.00. They now have a "buy" rating on the stock.
Low
Report
Oculis (NASDAQ:OCS) had its price target lowered by analysts at Bank of America Corporation from $30.00 to $29.00. They now have a "buy" rating on the stock.
11/11
08:09 am
ocs
Oculis (NASDAQ:OCS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Low
Report
Oculis (NASDAQ:OCS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/11
08:09 am
ocs
Oculis (NASDAQ:OCS) had its price target raised by analysts at HC Wainwright from $36.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Oculis (NASDAQ:OCS) had its price target raised by analysts at HC Wainwright from $36.00 to $42.00. They now have a "buy" rating on the stock.
11/11
08:08 am
ocs
Oculis (NASDAQ:OCS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $51.00 price target on the stock.
Low
Report
Oculis (NASDAQ:OCS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $51.00 price target on the stock.
11/10
05:27 pm
ocs
Oculis Holding GAAP EPS of CHF -0.32 [Seeking Alpha]
Low
Report
Oculis Holding GAAP EPS of CHF -0.32 [Seeking Alpha]
11/10
04:41 pm
ocs
Oculis Reports Q3 2025 Financial Results and Provides Company Update [Yahoo! Finance]
Low
Report
Oculis Reports Q3 2025 Financial Results and Provides Company Update [Yahoo! Finance]
11/10
04:05 pm
ocs
Oculis Reports Q3 2025 Financial Results and Provides Company Update
Low
Report
Oculis Reports Q3 2025 Financial Results and Provides Company Update
11/5
04:00 am
ocs
Oculis to Participate in Upcoming November Investor Conferences
Low
Report
Oculis to Participate in Upcoming November Investor Conferences
11/1
08:38 pm
ocs
Oculis Holding (OCS): Is the Premium Price-to-Book Ratio Justified After Recent Share Price Gains? [Yahoo! Finance]
Low
Report
Oculis Holding (OCS): Is the Premium Price-to-Book Ratio Justified After Recent Share Price Gains? [Yahoo! Finance]
10/30
04:30 am
ocs
Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development
Medium
Report
Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development
10/14
04:00 am
ocs
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
Medium
Report
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025